Congress Program
08:00
Registration
08:50
Congress Opening and Welcome
Roei Zerahia, Israel - Congress Chair
09:00-10:30
Session I: Cultivating Cannabis in Europe: Understanding Regulatory Frameworks and Compliance Requirements
The long dispute until legal certainty. From the first hemp store in 2004 to technology leadership in tissue culture’
Alexander Klima
Flowery Field GmbH, Austria
TBA
10:30-11:00
Coffee Break
11:00-12:30
Session II: The Road to Commercialization: Navigating European Regulations for Cannabis Manufacturing Facilities
Regulatory Framework and Supply Chain Management in Portugal and Europe’
Amit Edri
Portocanna, Portugal
Parallel Paths: Unraveling the Medicinal and Recreational Cannabis Landscapes in the Netherlands
Juriën Koster
KPSA, Netherlands
12:30-13:30
Lunch Break
13:30-15:00
Session III: Cutting through the Red Tape: Navigating Regulatory Requirements for Cannabis Clinical Trials in Europe
15:00-15:30
Coffee Break
15:30-17:00
Session IV: Blazing a Trail for Medical Cannabis: Insights from Israel's Pioneering Industry and Regulatory Framework
Medical Cannabis Research – how to regulate the plant
Nirit Bernstein
Head of Medical Cannabis Lab, Volcani Center, Ministry of Agriculture, Israel
Medicalization – ups and downs in the Israeli Industry
Roei Zerahia - Congress Chair
Shenkar College, Israel
08:00
Registration
09:00-10:30
Session V: A Green Future: Charting the Course of Cannabis Regulation and Legalization in Europe and Beyond
AGES – Past, present and future of regulation in Austria
Valentin Opfermann
AGES (Austrian Agency for Health and Food Safety GmbH), Austria
UK cannabis regulations: what’s right and what’s wrong
Callie Seaman
MedCan Support, UK
10:30-11:00
Coffee Break
11:00-12:30
Session VI: The Global Cannabis Economy: How Developing Countries Can Build Sustainable and Inclusive Cannabis Industries
Cannabis in Developing Countries
Wesley Petzer
Cannavigia, South Africa
TBA
12:30-13:30
Lunch Break
13:30-15:00
Session VII: From Lab to Shelf: Insights on Regulatory Compliance and Commercialization for Cannabis-Based Pharmaceuticals in Europe
Malta’s medical cannabis regulation: latest developments and state-of-play’
Jackie Grech
Malta Enterprise, Malta
Regulatory compliance and commercialization for Cannabis-based pharmaceutical products in Germany
Benedikt Sons
Cansativa Group, Germany
15:00-15:30
Coffee Break
15:30-16:45
Session VIII: The Next Big Thing: Predictions and Insights on the Future of the Industry: Cannabis, Psychedelics and Beyond
The Entourage Effect: The Synergy between Cannabis and Psychedelics industries
Omer Zerahia
Tel Aviv University, Israel
TBA
16:45-17:00
Congress Closing Remarks
Roei Zerahia, Israel - Congress Chair
